Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: Interaction with angiotensin type 2 receptors

Hypertension

Volumn 37, Issue 6, 2001, Pages 1399-1403

  Varagic, Jasmina ^a   Susic, Dinko ^a   Frohlich, Edward D ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

Angiotensin II receptors; Blood pressure; Fibrosis; Hemodynamics; Rats, inbred SHR

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; HYDROXYPROLINE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; CORONARY VASCULAR RESISTANCE; DOSE RESPONSE; HEART VENTRICLE; HEART WEIGHT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN BLOOD FLOW; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0035571382     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.6.1399     Document Type: Article

References (50)

1. Angiotensin receptors and their antagonist
2. Molecular insights into angiotensin II type 1 and type 2 receptors: Expression, signaling and physiological function and clinical application of its antagonists
3. Angiotensin receptors and their therapeutic implications
4. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function
5. 2 receptor mRNA during development of the rat kidney and adrenal gland
6. Angiotensin II type-2 receptor mRNA expression in the developing cardiopulmonary system of the rat
7. Characterization of angiotensin II receptor subtypes in rat heart
8. 2) receptor protein in rat heart
9. 2) receptor protein in rat heart
10. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
11. Role of the angiotensin subtype 2 receptor in neointima formation after vascular injury
12. 2 receptors subtypes in hypertrophied rat hearts
13. 1 receptor: Gain-of-function study using gene transfer
14. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
15. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats
16. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat
17. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR
18. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage
19. 1-receptor antagonist, in conscious spontaneously hypertensive rats
20. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats
21. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependant mcchanism
22. 2 receptor in a renal wrap hypertension model
23. Reference sample microsphere method: Cardiac output and blood flows in conscious rat
24. Role of site of microsphere injection and catheter position on systemic and regional hemodynamics in rat
25. Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats
26. Hemodynamic studies in spontaneously hypertensive rats with congenital arteriovenous shunts
27. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats
28. Changes in cardiovascular mass, left ventricular pumping ability, and aortic distensibility after calcium antagonist in Wistar-Kyoto and spontaneously hypertensive rats
29. Dissociation of changes in cardiovascular mass and performance with angiotensin converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats
30. Effects of quinapril on systemic and regional hemodynamics and cardiac mass in spontaneously hypertensive and Wistar-Kyoto rats
31. Renoprotective effects of felodipine and/or enalapril in spontaneously rats with and without L-NAME
32. Effect of methyldopa, clonidine and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats
33. Cardiovascular mass and ventricular function after celiprolol in Wistar-Kyoto and spontaneously hypertensive rats
34. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme
35. The effect of acute and chronic hematocrit changes on cardiovascular hemodynamics in spontaneously hypertensive rats
36. Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats
37. Losartan (DuP 753), an oral active nonpeptide angiotensin II receptor antagonist
38. Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats
39. ACE inhibition reduces left ventricular mass independent of pressure without affecting coronary flow and flow reserve in spontaneously hypertensive rats
40. Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade
41. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries
42. Collagen metabolism in cultured adult rat cardiac fibroblasts, response to angiotensin II and aldosterone
43. Renin-angiotensin system and myocardial collagen matrix: Modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism
44. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts
45. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type I receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors
46. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic handing in mice
47. Risk mechanisms in hypertensive heart disease
48. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression
49. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)